Related Experiment Video
Updated: Aug 10, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Steroids in adults with acute bacterial meningitis: a systematic review
Diederik van de Beek1, Jan de Gans, Peter McIntyre
1Department of Neurology, Academic Medical Centre, University of Amsterdam, Netherlands. D.vandeBeek@amc.uva.nl
Abstract:
Bacterial meningitis is uncommon but causes significant mortality and morbidity, despite optimum antibiotic therapy. A clinical trial in 301 patients showed a beneficial effect of adjunctive steroid treatment in adults with acute community-acquired pneumococcal meningitis, but data on other organisms or adverse events are sparse. This led us to do a quantitative systematic review of adjunctive steroid therapy in adults with acute bacterial meningitis. Five trials involving 623 patients were included (pneumococcal meningitis=234, meningococcal meningitis=232, others=127, unknown=30). Overall, treatment with steroids was associated with a significant reduction in mortality (relative risk 0.6, 95% CI 0.4-0.8, p=0.002) and in neurological sequelae (0.6, 0.4-1, p=0.05), and with a reduction of case-fatality in pneumococcal meningitis of 21% (0.5, 0.3-0.8, p=0.001). In meningococcal meningitis, mortality (0.9, 0.3-2.1) and neurological sequelae (0.5, 0.1-1.7) were both reduced, but not significantly. Adverse events, recorded in 391 cases, were equally divided between the treatment and placebo groups (1, 0.5-2), with gastrointestinal bleeding in 1% of steroid-treated and 4% of other patients. Since treatment with steroids reduces both mortality and neurological sequelae in adults with bacterial meningitis, without detectable adverse effects, routine steroid therapy with the first dose of antibiotics is justified in most adult patients in whom acute community-acquired bacterial meningitis is suspected.
Insights
Adjunctive steroid therapy significantly reduces mortality and neurological sequelae in adults with bacterial meningitis. This treatment is justified for suspected acute community-acquired bacterial meningitis, showing no detectable adverse effects.
Area of Science:
- Infectious Diseases
- Neurology
- Pharmacology
Background:
- Bacterial meningitis, though uncommon, leads to high mortality and morbidity even with optimal antibiotic treatment.
- Previous trials suggest adjunctive steroids benefit adults with pneumococcal meningitis, but data on other pathogens and adverse events are limited.
Purpose of the Study:
- To conduct a quantitative systematic review on the efficacy and safety of adjunctive steroid therapy in adults with acute bacterial meningitis.
Main Methods:
- Systematic review and meta-analysis of five randomized controlled trials involving 623 adult patients.
- Included patients had bacterial meningitis caused by various organisms, including Streptococcus pneumoniae and Neisseria meningitidis.
Main Results:
- Adjunctive steroids significantly reduced overall mortality (RR 0.6, 95% CI 0.4-0.8) and neurological sequelae (RR 0.6, 95% CI 0.4-1).
- A significant reduction in case-fatality was observed in pneumococcal meningitis (RR 0.5, 95% CI 0.3-0.8).
- Adverse events were similar between steroid and placebo groups, with no significant increase in gastrointestinal bleeding.
Conclusions:
- Adjunctive steroid therapy is associated with reduced mortality and neurological sequelae in adults with acute bacterial meningitis.
- Routine steroid administration with the first antibiotic dose is justified for suspected community-acquired bacterial meningitis in adults due to demonstrated benefits and lack of significant adverse effects.
Related Concept Videos
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction

